Paying user area
Try for free
Vertex Pharmaceuticals Inc. pages available for free this week:
- Income Statement
- Common-Size Balance Sheet: Assets
- Common Stock Valuation Ratios
- Enterprise Value to FCFF (EV/FCFF)
- Capital Asset Pricing Model (CAPM)
- Selected Financial Data since 2005
- Return on Equity (ROE) since 2005
- Return on Assets (ROA) since 2005
- Debt to Equity since 2005
- Price to Sales (P/S) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Vertex Pharmaceuticals Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Goodwill and Intangible Asset Disclosure
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
The analysis of the intangible assets over the five-year period reveals several noteworthy trends and changes.
- Goodwill
- The goodwill value remained relatively stable from 2020 through 2021 at approximately 1,002 million US dollars. It then increased to 1,088 million US dollars in 2022 and held steady through 2024.
- In-Process Research and Development
- This asset category maintained a consistent value of 400 million US dollars in 2020 and 2021, followed by an increase to 603.6 million US dollars in 2022 through 2024, indicating significant capitalized investments in ongoing research projects beginning in 2022.
- Marketed Products
- Values for marketed products appear starting in 2023 at 238 million US dollars and remained unchanged in 2024. The introduction of this asset category in the later periods suggests acquisition or internal development recognition of commercialized products.
- Assembled Workforce
- This intangible asset was reported beginning in 2024, with a value of 7.7 million US dollars, indicating a recent recognition possibly linked to acquisitions or workforce-related valuations.
- Finite-Lived Intangible Assets, Gross Carrying Amount
- Values for this item are only present in 2023 and 2024, showing growth from 238 million to 245.7 million US dollars, implying additions or revaluation of limited useful life assets during this period.
- Accumulated Amortization
- The accumulated amortization recorded negative values in 2023 (-1.7 million) and increased substantially in 2024 (-23.4 million), reflecting ongoing amortization expenses related to finite-lived intangibles.
- Finite-Lived Intangible Assets, Net Carrying Amount
- Net carrying amount decreased slightly from 236.3 million in 2023 to 222.3 million in 2024, consistent with amortization trends and possibly indicating asset consumption or impairment effects.
- Other Intangible Assets, Net
- This aggregate asset category increased from 400 million in 2020 and 2021 to 603.6 million in 2022 and further rose to 839.9 million in 2023 before slightly decreasing to 825.9 million in 2024. This suggests overall growth in intangible assets, possibly from acquisitions or internal development, with minor reductions due to amortization or impairments.
- Goodwill and Other Intangible Assets (Total)
- The combined total value rose progressively from approximately 1.4 billion US dollars in 2020 and 2021 to 1.69 billion in 2022, reaching a peak of 1.93 billion in 2023 before marginally declining to 1.91 billion in 2024. This trend reflects significant net increases in intangible assets, tempered by amortization and potential disposals or impairments in the most recent year.
Overall, the data indicates a period of asset growth predominantly driven by increases in in-process research and development and the emergence of marketed products and assembled workforce intangible assets from 2023 onwards. While goodwill stabilized after an initial increase, other intangible assets showed consistent expansion. The growing amortization charges in 2023 and 2024 suggest an increasing impact of finite-lived assets on expenses, contributing to a slight decline in net intangible asset values despite overall gross asset additions.
Adjustments to Financial Statements: Removal of Goodwill
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
- Total Assets
- The reported total assets have shown consistent growth from 11.75 billion US dollars in 2020 to a peak of 22.73 billion in 2023, followed by a slight decline to 22.53 billion in 2024. The adjusted total assets, which exclude goodwill, follow a similar pattern, increasing steadily from 10.75 billion in 2020 to 21.64 billion in 2023 before a minor decrease to 21.45 billion in 2024. This indicates that the majority of the asset base expansion over the years is supported by tangible and other recognized assets, with a stable proportion of goodwill.
- Shareholders’ Equity
- Reported shareholders’ equity also displays a robust upward trend, rising from approximately 8.69 billion US dollars in 2020 to a peak of 17.58 billion in 2023, before contracting to 16.41 billion in 2024. The adjusted shareholders’ equity figures, which remove goodwill effects, mirror this trajectory, starting at 7.68 billion in 2020, reaching 16.49 billion in 2023, and then declining slightly to 15.32 billion in 2024. This suggests that the intrinsic equity value growth is substantial, although there is a notable reduction in 2024.
- Trends and Insights
- Overall, both reported and adjusted figures indicate strong asset growth and equity expansion over the five-year period, reflecting potentially successful operational and investment activities. The adjustment for goodwill consistently reduces both asset and equity values, but the gap remains relatively stable, implying that goodwill’s proportion has not significantly fluctuated. The slight decline in both asset and equity values in 2024 may merit attention, possibly indicating changes in valuation, divestitures, or impairment considerations.
Vertex Pharmaceuticals Inc., Financial Data: Reported vs. Adjusted
Adjusted Financial Ratios: Removal of Goodwill (Summary)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
The financial data depicts trends in asset turnover, financial leverage, return on equity (ROE), and return on assets (ROA) for the analyzed periods from 2020 through 2024. Both reported and goodwill adjusted figures are presented, facilitating a comparative analysis of operational efficiency and profitability before and after adjustments related to goodwill.
- Total Asset Turnover
- Reported total asset turnover demonstrates a declining trend from 0.53 in 2020 to a low of 0.43 in 2023, with a partial recovery to 0.49 in 2024. The adjusted total asset turnover mirrors this pattern, starting at 0.58 in 2020, decreasing to 0.46 in 2023, and slightly improving to 0.51 in 2024. These movements suggest a gradual reduction in the efficiency of asset use to generate revenue over the initial years, with some improvement noted in the final year.
- Financial Leverage
- Financial leverage ratios, both reported and adjusted, remain relatively stable over the period, fluctuating narrowly between 1.29 and 1.40. The reported financial leverage slightly decreases from 1.35 in 2020 to 1.29 in 2023 before rising again to 1.37 in 2024. Adjusted financial leverage follows a similar trajectory. This stability indicates consistent use of debt relative to equity, with no significant shifts in the company’s capital structure during these years.
- Return on Equity (ROE)
- Reported ROE shows a notable decline, falling from a robust 31.22% in 2020 to 20.59% in 2023, before dropping significantly into negative territory at -3.26% in 2024. Adjusted ROE follows a similar pattern, starting higher at 35.29% in 2020 and decreasing steadily to -3.50% in 2024. The sharp decline into negative ROE in the final year suggests substantial challenges affecting profitability or equity base.
- Return on Assets (ROA)
- Similar to ROE, reported ROA decreases from 23.07% in 2020 to 15.92% in 2023, then turns negative at -2.38% in 2024. The adjusted ROA, starting at 25.23% in 2020, follows the same declining trend with a drop to -2.50% in 2024. This consistent decline in asset returns reflects reduced overall profitability and efficiency in asset utilization to generate earnings.
In summary, the data indicate a period of diminishing operational efficiency and profitability over the years examined, with both reported and adjusted metrics evidencing this trend. While asset turnover shows some resilience by recovering slightly in the last period, returns on equity and assets experience significant deterioration, culminating in negative results in 2024. The stability of financial leverage suggests that these changes are not driven by increased financial risk or changes in capital structure but possibly reflect operational or market challenges impacting net income and asset performance.
Vertex Pharmaceuticals Inc., Financial Ratios: Reported vs. Adjusted
Adjusted Total Asset Turnover
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
2024 Calculations
1 Total asset turnover = Revenues ÷ Total assets
= ÷ =
2 Adjusted total asset turnover = Revenues ÷ Adjusted total assets
= ÷ =
The financial data presents an overview of reported and goodwill-adjusted total assets alongside the respective total asset turnover ratios over a five-year period ending in 2024.
- Total Assets
- The reported total assets have exhibited a consistent upward trend from 11,751,808 thousand US dollars in 2020 to a peak of 22,730,200 thousand US dollars in 2023. However, there is a slight decline noted in 2024, where total assets decreased marginally to 22,533,200 thousand US dollars. A similar pattern is observed in the adjusted total assets, which exclude goodwill. The adjusted figures also rose steadily from 10,749,650 thousand US dollars in 2020, reaching 21,642,200 thousand US dollars in 2023, before decreasing slightly to 21,445,200 thousand US dollars in 2024.
- Total Asset Turnover Ratios
- Both reported and adjusted total asset turnover ratios show a general decline over the period in review. The reported asset turnover started at 0.53 in 2020, increased slightly to 0.56 in 2021, then gradually declined to 0.43 by 2023 and rebounded to 0.49 in 2024. The adjusted total asset turnover followed a similar pattern, beginning at 0.58 in 2020, peaking at 0.61 in 2021, decreasing steadily to 0.46 in 2023, and moving up to 0.51 in 2024.
- Insights and Patterns
- The increase in total assets over the initial four years suggests ongoing investment and growth in asset base, both in reported terms and when adjusted for goodwill. The slight reduction in assets in 2024 could indicate divestitures or asset revaluations. The declining asset turnover ratios over most of the period imply that revenue relative to the asset base has decreased, reflecting a possible slowdown in efficiency or market conditions impacting asset productivity. The modest recovery in turnover ratios in 2024 may indicate an improvement in utilizing assets to generate revenue.
Adjusted Financial Leverage
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
2024 Calculations
1 Financial leverage = Total assets ÷ Shareholders’ equity
= ÷ =
2 Adjusted financial leverage = Adjusted total assets ÷ Adjusted shareholders’ equity
= ÷ =
- Total Assets
- Total assets show a consistent upward trend from 2020 to 2023, increasing from approximately $11.75 billion to $22.73 billion. In 2024, there is a slight decrease to $22.53 billion. Adjusted total assets follow a very similar pattern, rising steadily each year through 2023 and then marginally declining in 2024. This indicates growth in the company’s asset base over the five-year period, with a minor contraction in the most recent year.
- Shareholders’ Equity
- Reported shareholders’ equity has increased significantly from about $8.69 billion in 2020 to a peak of $17.58 billion in 2023, followed by a decline to $16.41 billion in 2024. The adjusted shareholders’ equity figures mirror this pattern closely but remain consistently lower than reported equity, reflecting the impact of goodwill adjustments. The adjustments appear to reduce equity by roughly 10-12%, indicating notable goodwill included in reported figures. Overall, equity growth from 2020 to 2023 is strong, with a slight reversal in 2024.
- Financial Leverage
- Both reported and adjusted financial leverage ratios demonstrate a gradual decline from 2020 through 2023, suggesting a reduction in leverage or relative increase in equity over liabilities during this period. Reported leverage falls from 1.35 to 1.29, while adjusted leverage decreases from 1.4 to 1.31. However, in 2024, both measures increase abruptly to 1.37 and 1.40, respectively, indicating a rise in leverage or a relative increase in liabilities. The adjusted leverage ratio consistently remains slightly higher than the reported ratio, consistent with lower equity values after goodwill adjustments.
- Overall Insights
- The company has experienced considerable growth in total assets and shareholders’ equity between 2020 and 2023, suggesting expansion and capital buildup. This trend reverses slightly in 2024, with small declines in asset and equity balances. The leverage metrics indicate improved financial structure with lower leverage over most of the period but show increased leverage at the end, which may be a point for closer monitoring. Goodwill adjustments notably reduce equity and increase leverage ratios, underscoring the importance of intangible asset considerations in assessing financial strength.
Adjusted Return on Equity (ROE)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
2024 Calculations
1 ROE = 100 × Net income (loss) ÷ Shareholders’ equity
= 100 × ÷ =
2 Adjusted ROE = 100 × Net income (loss) ÷ Adjusted shareholders’ equity
= 100 × ÷ =
The financial data reveals several notable trends regarding the equity position and return on equity (ROE) over the five-year period.
- Shareholders’ Equity
- The reported shareholders’ equity shows consistent growth from 2020 through 2023, increasing from approximately 8.69 billion US dollars to 17.58 billion. However, in 2024 there is a decline to around 16.41 billion, indicating a reduction after years of growth. The adjusted shareholders’ equity, which presumably excludes goodwill or other adjustments, follows a similar pattern, rising steadily from about 7.68 billion in 2020 to 16.49 billion in 2023 before decreasing to 15.32 billion in 2024. This alignment between reported and adjusted equity trends suggests the adjustments do not materially alter the overall equity trajectory.
- Return on Equity (ROE)
- Both reported and adjusted ROE exhibit a declining trend over the observed period. Reported ROE starts high at 31.22% in 2020, then decreases year over year to 20.59% in 2023, followed by a sharp drop to a negative value of -3.26% in 2024. Adjusted ROE follows a very similar path, beginning at 35.29% in 2020, declining to 21.95% in 2023, and then falling to -3.5% in 2024. The similarity between reported and adjusted ROE figures implies that goodwill adjustments have limited impact on the underlying profitability metrics.
- Insights and Observations
- The increasing equity base through 2023 indicates capital growth and possibly retained earnings accumulation or new equity issuance. However, the simultaneous decline in ROE suggests that net income growth has not kept pace with the equity base expansion, leading to reduced profitability relative to equity. The negative ROE in 2024 signals a net loss or substantial financial downturn that outweighs equity levels. This deterioration in profitability warrants further investigation into operating performance or extraordinary events impacting the fiscal year 2024.
Adjusted Return on Assets (ROA)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
2024 Calculations
1 ROA = 100 × Net income (loss) ÷ Total assets
= 100 × ÷ =
2 Adjusted ROA = 100 × Net income (loss) ÷ Adjusted total assets
= 100 × ÷ =
The financial data reveals several noteworthy trends concerning the reported and goodwill-adjusted total assets and return on assets (ROA) over the five-year period.
- Total Assets
- There is a consistent upward trend in both reported and adjusted total assets from 2020 through 2023, with reported assets increasing from approximately 11.75 billion USD to 22.73 billion USD, and adjusted assets showing a similar rise from about 10.75 billion USD to 21.64 billion USD. However, in 2024, a slight decline occurs in both measures, with reported total assets decreasing to approximately 22.53 billion USD and adjusted total assets reducing to about 21.45 billion USD. This recent dip follows several years of substantial growth.
- Return on Assets (ROA)
- ROA indicators demonstrate a declining trend over the observed period. Both reported and adjusted ROA start at strong levels of 23.07% and 25.23% respectively in 2020. While there is some fluctuation between 2021 and 2023, with ROA figures generally decreasing, adjusted ROA remains slightly higher than reported ROA each year. A significant development is observed in 2024, where ROA sharply turns negative, registering -2.38% for reported and -2.5% for adjusted figures. This suggests a notable deterioration in asset profitability in the most recent year.
Overall, the data reflects a period of asset growth accompanied by declining profitability in terms of ROA, culminating in a negative return in 2024 despite substantial asset base. The goodwill adjustment maintains consistently higher ROA percentages but does not alter the overall downward and negative profitability trend.